XF Drug Platform
Small molecule drug platform rapidly bactericidal with unique mechanisms of action
A platform of porphyrin molecules with antimicrobial activity intended for topical application for the treatment or prevention of infection
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action.
- Infection prevention
- Antimicrobial compounds
Co-development, licensing, and outsourcing are all parts of the Destiny pharma business model.
Destiny Pharma plc is a clinical stage, virtual biotech company